IM Cannabis Corp.
IMCC
IM Cannabis Corp. is an international medical cannabis company focused on importing, distributing, and selling cannabis-based products for medical patients in Israel and Germany. The company offers dried flower and full-spectrum cannabis extract products under brands including IMC, BLKMT, and LOT420, with a business model centered on regulated medical markets and pharmacy-based supply chains. Its operations include product sourcing, quality control, and market-specific distribution across Europe and the Middle East, supporting physicians, pharmacies, and patients who rely on standardized cannabis formulations. IM Cannabis Corp. also maintains an online and retail presence tied to its medical cannabis ecosystem, reinforcing its role as a specialized supplier within the healthcare and life sciences sectors. Headquartered in Kibbutz Glil-Yam, Israel, the company remains positioned as a focused participant in the growing regulated medical cannabis market.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
C$51M
▲ +1.3% YoY
Net Income (TTM)
-C$14M
▲ +0.2% YoY
Op. Margin
-26.36%
▼ -2.2pp YoY
ROIC
-48.92%
▼ -15.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
C$49K
▲ +481.4% YoY
Op. Cash Flow (TTM)
C$67K
▲ +502.0% YoY
Net Debt
C$14M
Cash & Equiv.
C$3M
3Y CAGR: +0.2%
Continue Research
Peers
Drug Manufacturers - Specialty & Generic · Pick stocks to compare with IMCC
IM Cannabis (IMCC) in four numbers
Questions about IM Cannabis
Is IM Cannabis (IMCC) overvalued?
At $0.51, IM Cannabis' price is 94% below the $8.55 a share fair value that Intrinsiqq's calculator gets from its revenue. It trades at 87.82 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is IM Cannabis' fair value?
Intrinsiqq's calculator puts IM Cannabis' fair value at $8.55 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 2.3, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $6.41. Every input can be changed on the Intrinsic Value tab.
Is IM Cannabis a high-quality business?
IM Cannabis scores 30 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from company filings. Its best check is margin trend at +15.1pp, and its weakest is return on capital at -48.9%. The Quality tab shows every check against its target.
Does IM Cannabis (IMCC) pay a dividend?
No. IM Cannabis (IMCC) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing IMCC
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.